Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.

    Rare Community Profiles: From the 1960s to Now: How Two Hemophilia Advocates Have Seen Treatment and Research Progress
    source: shutterstock.com

    Rare Community Profiles: From the 1960s to Now: How Two Hemophilia Advocates Have Seen Treatment and Research Progress

    Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

    Continue Reading Rare Community Profiles: From the 1960s to Now: How Two Hemophilia Advocates Have Seen Treatment and Research Progress
    Rare Community Profiles: How Derrick’s Colorectal Cancer Journey Led Him to Advocate for Increased Biomarker Testing
    source: shutterstock.com

    Rare Community Profiles: How Derrick’s Colorectal Cancer Journey Led Him to Advocate for Increased Biomarker Testing

    Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

    Continue Reading Rare Community Profiles: How Derrick’s Colorectal Cancer Journey Led Him to Advocate for Increased Biomarker Testing
    2024 Proof-of-Concept Trial Will Evaluate DNTH103 for Cold Agglutinin Disease (CAD)
    source: pixabay.com

    2024 Proof-of-Concept Trial Will Evaluate DNTH103 for Cold Agglutinin Disease (CAD)

    According to an article published in Cold Agglutinin News, Dianthus Therapeutics (“Dianthus”) is planning on holding a proof-of-concept study in 2024. Within the study, the company would evaluate the safety…

    Continue Reading 2024 Proof-of-Concept Trial Will Evaluate DNTH103 for Cold Agglutinin Disease (CAD)
    Rep. Jamie Raskin Shares Update on DLBCL, Says He is in Remission
    https://pixabay.com/en/united-states-capitol-politics-1675539/

    Rep. Jamie Raskin Shares Update on DLBCL, Says He is in Remission

    In December 2022, Representative Jamie Raskin (D-MD) shared with the public that he had been diagnosed with diffuse large B-cell lymphoma (DLBCL). Although being diagnosed with cancer can be frightening,…

    Continue Reading Rep. Jamie Raskin Shares Update on DLBCL, Says He is in Remission
    BDGR-49 Could Be Effective Against Eastern Equine Encephalitis (EEE) and Venezuelan Equine Encephalitis (VEE)
    WimdeGraaf / Pixabay

    BDGR-49 Could Be Effective Against Eastern Equine Encephalitis (EEE) and Venezuelan Equine Encephalitis (VEE)

    People with severe cases of Eastern equine encephalitis (EEE) or Venezuelan equine encephalitis (VEE) can develop significant brain inflammation, causing damage. An estimated 33% of people with severe EEE infection,…

    Continue Reading BDGR-49 Could Be Effective Against Eastern Equine Encephalitis (EEE) and Venezuelan Equine Encephalitis (VEE)
    THIS WEEKEND: The Twin Run – Supporting High Risk Multiple Birth Parents And Twin Research
    Photo courtesy of TAPS Support

    THIS WEEKEND: The Twin Run – Supporting High Risk Multiple Birth Parents And Twin Research

    This weekend during the Leiden Marathon, more than 30 parents, children, doctors, researchers and members of the public will run to raise money for the Well Bee Study.  This important…

    Continue Reading THIS WEEKEND: The Twin Run – Supporting High Risk Multiple Birth Parents And Twin Research

    Generic Budesonide Rectal Foam Now Approved for Mild-to-Moderate Ulcerative Colitis

    In the past, budesonide has been used in a number of therapeutic indications, such as to reduce proteinuria in IgA nephropathy or digestive tract inflammation in those with Crohn's disease.…

    Continue Reading Generic Budesonide Rectal Foam Now Approved for Mild-to-Moderate Ulcerative Colitis
    Clinical Practice Update Encourages Understanding of GI Symptoms Relating to Alpha-Gal Syndrome
    source: pixabay.com

    Clinical Practice Update Encourages Understanding of GI Symptoms Relating to Alpha-Gal Syndrome

    Have you been struggling with gastrointestinal (GI) issues? Does your stomach ache? Have you been throwing up or experiencing diarrhea—but you’re not quite sure why? Well, you might have alpha-gal…

    Continue Reading Clinical Practice Update Encourages Understanding of GI Symptoms Relating to Alpha-Gal Syndrome
    His Experience with Dupuytren’s Contracture Led Him to Launch a Venture to Advance Treatment
    source: pixabay.com

    His Experience with Dupuytren’s Contracture Led Him to Launch a Venture to Advance Treatment

    It all began at a movie theater. Kurt Harrington and his father were leaving the theater when his father decided to hold the door open for some others. Someone knocked…

    Continue Reading His Experience with Dupuytren’s Contracture Led Him to Launch a Venture to Advance Treatment
    Rare Community Profiles: This Rare Family is Managing CVID, MS, UC, and Double Cortex Syndrome: Here’s How You Can Help
    source: shutterstock.com

    Rare Community Profiles: This Rare Family is Managing CVID, MS, UC, and Double Cortex Syndrome: Here’s How You Can Help

    Rare Community Profiles   Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families,…

    Continue Reading Rare Community Profiles: This Rare Family is Managing CVID, MS, UC, and Double Cortex Syndrome: Here’s How You Can Help
    Rare Community Profiles: CureDuchenne Clinic in Greater Dallas Area Aims to Improve Treatment Accessibility and Care for Underserved Families with DMD and BMD
    source: shutterstock.com

    Rare Community Profiles: CureDuchenne Clinic in Greater Dallas Area Aims to Improve Treatment Accessibility and Care for Underserved Families with DMD and BMD

    Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

    Continue Reading Rare Community Profiles: CureDuchenne Clinic in Greater Dallas Area Aims to Improve Treatment Accessibility and Care for Underserved Families with DMD and BMD
    Rare Community Profiles: Dr. Jonathan Barratt Discusses Phase 2b Data on Atacicept for IgA Nephropathy
    source: shutterstock.com

    Rare Community Profiles: Dr. Jonathan Barratt Discusses Phase 2b Data on Atacicept for IgA Nephropathy

    Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

    Continue Reading Rare Community Profiles: Dr. Jonathan Barratt Discusses Phase 2b Data on Atacicept for IgA Nephropathy
    Blinatumomab Immunotherapy is Effective for Infants with Aggressive Acute Lymphoblastic Leukemia (ALL)
    192635 / Pixabay

    Blinatumomab Immunotherapy is Effective for Infants with Aggressive Acute Lymphoblastic Leukemia (ALL)

      KMT2A rearrangements—a DNA fault—lead to treatment-resistant acute lymphoblastic leukemia (ALL) in infants. While around 50% of children with KMT2A rearrangements respond well to intensive chemotherapy, the remaining 50% do…

    Continue Reading Blinatumomab Immunotherapy is Effective for Infants with Aggressive Acute Lymphoblastic Leukemia (ALL)